Denali Therapeutics Inc (DNLI)

Jul 06, 2026

Amyotrophic Lateral Sclerosis Market Trends, Innovation, and Future Growth Outlook to 2036 – DelveInsight | Helixmith, Sanofi, Denali Therapeutics, Transposon Therapeutics, GSK, Biogen, Ionis Pharma - Barchart.com

Jul 06, 2026

Jul 06, 2026

Trading Systems Reacting to (DNLI) Volatility - Stock Traders Daily

Jul 06, 2026

Jul 06, 2026

DNLIDenali Therapeutics Inc Volatility & Greeks - Finviz

Jul 06, 2026

Jul 05, 2026

Denali Therapeutics (DNLI) Looks Fully Valued Following Its 32% 30 Day Rally - Sahm

Jul 05, 2026

Jul 03, 2026

Denali Therapeutics stock stays focused on pipeline progress. - AD HOC NEWS

Jul 03, 2026

Jul 01, 2026

Amyotrophic Lateral Sclerosis Market Gains Momentum with Expanding Pipeline and Investment Potential by 2034 – DelveInsight | Helixmith, Sanofi, Denali Therapeutics, Transposon Therapeutics, GSK - Barchart.com

Jul 01, 2026

Jun 29, 2026

Denali to sell priority review voucher for $195M cash boost - MSN

Jun 29, 2026

Jun 27, 2026

Enterprise value to EBIT forward of Denali Therapeutics Inc. – NASDAQ:DNLI - TradingView

Jun 27, 2026

Jun 27, 2026

Price to sales forward of Denali Therapeutics Inc. – NASDAQ:DNLI - TradingView

Jun 27, 2026

Jun 27, 2026

Denali Therapeutics Inc (DNLI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 27, 2026

Jun 26, 2026

Denali Therapeutics Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.2 Sh - TradingView

Jun 26, 2026

Jun 26, 2026

Price to earnings forward of Denali Therapeutics Inc. – NASDAQ:DNLI - TradingView

Jun 26, 2026

Jun 26, 2026

Price to book forward of Denali Therapeutics Inc. – NASDAQ:DNLI - TradingView

Jun 26, 2026

Jun 26, 2026

Denali Therapeutics Inc. Actuals & Estimates (NASDAQ:DNLI) - TradingView

Jun 26, 2026

Jun 26, 2026

Enterprise value to EBITDA forward of Denali Therapeutics Inc. – NASDAQ:DNLI - TradingView

Jun 26, 2026

Jun 26, 2026

4DN Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026

Jun 26, 2026

Denali Therapeutics Inc. Actuals & Estimates (DUS:4DN) - TradingView

Jun 26, 2026

Jun 25, 2026

How Denali Therapeutics Inc. (DNLI) Affects Rotational Strategy Timing - Stock Traders Daily

Jun 25, 2026

Jun 25, 2026

Denali Therapeutics options trading jumps to 2,291 contracts By Investing.com - Investing.com India

Jun 25, 2026

Jun 25, 2026

Denali Therapeutics options trading jumps to 2,291 contracts - Investing.com

Jun 25, 2026

Jun 25, 2026

Denali Therapeutics stock hits 52-week high at 25.74 USD By Investing.com - Investing.com Nigeria

Jun 25, 2026

Jun 25, 2026

Denali Therapeutics stock hits 52-week high at 25.74 USD - Investing.com

Jun 25, 2026

Jun 25, 2026

DNLI Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Jun 25, 2026

We're Not Very Worried About Denali Therapeutics' (NASDAQ:DNLI) Cash Burn Rate - Moomoo

Jun 25, 2026

Jun 24, 2026

Denali Therapeutics (DNLI) Q1 2026 earnings summary - Quartr

Jun 24, 2026

Jun 23, 2026

Denali Therapeutics Sells Rare Pediatric Disease Priority Review Voucher for $195 Million - Global Legal Chronicle

Jun 23, 2026

Jun 23, 2026

Regenxbio Shares Rise on Plans to Resubmit Navsunli BLA for MPS II - Yahoo Finance

Jun 23, 2026

Jun 23, 2026

Denali Therapeutics (DNLI) Looks Fully Valued After $195 Million Voucher Sale - Sahm

Jun 23, 2026

Jun 22, 2026

Why Denali Therapeutics (DNLI) Is Up 8.2% After Selling Its Priority Review Voucher For $195 Million - simplywall.st

Jun 22, 2026

Jun 22, 2026

Stifel reiterates Buy rating on Denali Therapeutics stock at $41 By Investing.com - Investing.com Nigeria

Jun 22, 2026

Jun 22, 2026

Stifel reiterates Buy rating on Denali stock, cites launch progress By Investing.com - Investing.com India

Jun 22, 2026

Jun 22, 2026

Stifel reiterates Buy rating on Denali Therapeutics stock at $41 - Investing.com

Jun 22, 2026

Jun 22, 2026

Stifel reiterates Buy rating on Denali stock, cites launch progress - Investing.com

Jun 22, 2026

Jun 20, 2026

Denali to sell priority review voucher for $195M - MSN

Jun 20, 2026

Jun 19, 2026

Denali Therapeutics StockAnalyst focus and sector check after a quiet news week - AD HOC NEWS

Jun 19, 2026

Jun 19, 2026

Denali to Sell Priority Review Voucher for $195M Cash Boost - TradingView

Jun 19, 2026

Jun 19, 2026

Denali Monetizes Rare Pediatric Disease Voucher In $195m Deal After Avlayah FDA Nod - insights.citeline.com

Jun 19, 2026

Jun 18, 2026

Sector Update: Healthcare Stocks Advance Premarket Thursday - Moomoo

Jun 18, 2026

Jun 18, 2026

Denali Therapeutics Files 8-K Report Detailing Company Information and Latest Press Release – June 2026 - Minichart

Jun 18, 2026

Jun 18, 2026

Denali Therapeutics to sell priority review voucher for $195m - Investing.com

Jun 18, 2026

Jun 18, 2026

Denali Therapeutics to sell priority review voucher for $195m By Investing.com - Investing.com South Africa

Jun 18, 2026

Jun 18, 2026

Denali Therapeutics Inc (DNLI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 18, 2026

Jun 18, 2026

Denali Therapeutics Inc (DNLI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 18, 2026

Jun 18, 2026

Denali to sell priority review voucher for $195M (DNLI:NASDAQ) - Seeking Alpha

Jun 18, 2026